5 days ago
BMRN
AnalystsJoon LeeJoon Lee's Stock Forecasts
AnalystsJoon Lee
Sectors:
Industries:
Analyst Ranking
Top 2%
#90 out of 5087 analysts
Average Return
+41.08%
Win Rate
61%74 out of 122
Risk vs Reward
Poor
Good
Joon Lee's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Verona Pharma PLCVRNA | +548.82% | $14.46 | $93.82 | 2024-06-28 - 2025-06-27 | Strong Buy |
Praxis Precision Medicines IncPRAX | +492.43% | $33.55 | $198.76 | 2025-03-03 - 2025-10-31 | Strong Buy |
Viking Therapeutics IncVKTX | +470.38% | $10.87 | $62.00 | 2023-10-02 - 2024-10-01 | Strong Buy |
Intellia Therapeutics IncNTLA | +418.87% | $25.44 | $132.00 | 2020-10-27 - 2021-10-26 | Strong Buy |
Viking Therapeutics IncVKTX | +414.75% | $15.93 | $82.00 | 2023-03-29 - 2024-03-28 | Strong Buy |
Joon Lee Analyst Color
Get additional color on Joon Lee's coverage of popular stocks
16 days ago
PRAX
2 months ago
ARGX
3 months ago
PTCT
7 months ago
CORT
8 months ago
AXSM
9 months ago
CRSP
9 months ago
AXSM
10 months ago
ARGX
10 months ago
AXSM
10 months ago
VRNA
a year ago
WVE
a year ago
CPRX
a year ago
ARGX
a year ago
CRMD
a year ago
VRNA
a year ago
CORT
a year ago
CPRX
a year ago
ARGX
a year ago
VRNA
a year ago
ARGX
a year ago
CORT
2 years ago
ARGX
2 years ago
VKTX
2 years ago
CORT
Joon Lee's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Biomarin Pharmaceutical IncBMRN | 3 | Strong Buy | $80.00 | +49.34% | Maintains | 5 days ago |
Praxis Precision Medicines IncPRAX | 6 | Strong Buy | $360.00 | +81.12% | Reiterates | 16 days ago |
Rapport Therapeutics IncRAPP | 1 | Strong Buy | $44.00 | +52.09% | Initiates Coverage On | 2 months ago |
Argenx SeARGX | 13 | Strong Buy | $918.00 | +12.16% | Maintains | 2 months ago |
Vertex Pharmaceuticals IncVRTX | 4 | Strong Buy | $490.00 | +15.14% | Maintains | 3 months ago |
Ptc Therapeutics IncPTCT | 2 | Strong Buy | $86.00 | +25.90% | Maintains | 3 months ago |
Sage Therapeutics IncSAGE | 8 | Hold | $9.00 | +3.69% | Maintains | 5 months ago |
Viking Therapeutics IncVKTX | 8 | Strong Buy | $75.00 | +96.95% | Reiterates | 6 months ago |
Arvinas IncARVN | 6 | Strong Buy | $21.00 | +107.10% | Maintains | 7 months ago |
Corcept Therapeutics IncCORT | 8 | Strong Buy | $150.00 | +104.16% | Maintains | 7 months ago |
Intellia Therapeutics IncNTLA | 4 | Strong Buy | $50.00 | +296.20% | Maintains | 8 months ago |
Axsome Therapeutics IncAXSM | 5 | Strong Buy | $200.00 | +48.16% | Maintains | 8 months ago |
Crispr Therapeutics AgCRSP | 5 | Strong Buy | $120.00 | +87.53% | Maintains | 9 months ago |
Larimar Therapeutics IncLRMR | 1 | Strong Buy | $18.00 | +362.72% | Initiates Coverage On | 9 months ago |
Verona Pharma PLCVRNA | 6 | Strong Buy | $57.00 | -46.68% | Reiterates | 10 months ago |
Solid Biosciences IncSLDB | 1 | Strong Buy | $16.00 | +196.85% | Initiates Coverage On | 10 months ago |
Wave Life Sciences LtdWVE | 3 | Strong Buy | $36.00 | +298.23% | Maintains | a year ago |
Catalyst Pharmaceuticals IncCPRX | 7 | Strong Buy | $36.00 | +69.25% | Maintains | a year ago |
Editas Medicine IncEDIT | 7 | Strong Buy | $8.00 | +159.74% | Maintains | a year ago |
Cormedix IncCRMD | 6 | Strong Buy | $17.00 | N/A | Maintains | a year ago |
Longboard Pharmaceuticals IncLBPH | 2 | Hold | $60.00 | N/A | Downgrades | a year ago |
Adverum Biotechnologies IncADVM | 6 | Strong Buy | $40.00 | N/A | Maintains | a year ago |
Marinus Pharmaceuticals IncMRNS | 7 | Strong Buy | $10.00 | N/A | Maintains | a year ago |
Jazz Pharmaceuticals PLCJAZZ | 2 | Strong Buy | $200.00 | N/A | Reiterates | 2 years ago |
Taysha Gene Therapies IncTSHA | 7 | Strong Buy | $5.00 | N/A | Maintains | 2 years ago |
Voyager Therapeutics IncVYGR | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 2 years ago |
Concert Pharmaceuticals IncCNCE | 2 | Strong Buy | $25.00 | N/A | Maintains | 3 years ago |
Aptinyx IncAPTX | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Cyclerion Therapeutics IncCYCN | 1 | Strong Buy | $280.00 | N/A | Initiates Coverage On | 4 years ago |
Global Blood Therapeutics IncGBT | 1 | Strong Buy | $50.00 | N/A | Upgrades | 4 years ago |
Translate Bio IncTBIO1 | 2 | Hold | $360.00 | N/A | Downgrades | 5 years ago |
Anaptysbio IncANAB | 1 | Strong Buy | $34.00 | N/A | Upgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.